Skip to content
All Podcasts – Lifestyle
Author:
ITM Isotope Technologies Munich SE
ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026
March 4, 2026
←
Previous Page
1
2